Dr. Kurt M Dearnbarger, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 South Railroad St., Lovington, IL 61937 Phone: 217-873-5851 Fax: 217-873-1599 |
News Archive
Resverlogix Corp. has announced that it has received approval by the US Food and Drug Administration (FDA) to initiate a Phase 1a clinical trial of oral RVX-208 in the USA. RVX-208 is a novel first-in-class small molecule that increases the production of ApoA-I and HDL.
Chronic obstructive pulmonary disease (COPD) is considered the fourth most common cause of death in the United States. Usually the precursor to this life-threatening lung disease is a chronic bronchitis. Partially destroyed alveoli and an over-inflation of the lungs, known as emphysema, are serious side effects. However, the subtle differences in the tissue are barely discernable in standard X-ray images.
On Oct. 8, MicroMed Cardiovascular (www.micromedcv.com), manufacturer of the HeartAssist 5™ left ventricular assist device (LVAD), was selected as one of the Top 50 Emerging Companies in the nation's largest venture capital competition, the Sixth Annual Pitching Across America competition.
In Chicago, 7 percent of parents said that their child or children were limited or prevented in their ability to do things most peers can do, according to the latest survey results released by Ann & Robert H. Lurie Children's Hospital of Chicago and the Chicago Department of Public Health.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
› Verified 2 days ago